Vyteris, Inc.
13-01 Pollitt Drive
Fair Lawn
New Jersey
07410
United States
Tel: 201-703-2299
Fax: 201-703-2295
Website: http://www.vyteris.com/
Email: info@vyteris.com
49 articles about Vyteris, Inc.
-
Vyteris, Inc. Wants Out of Delivery Tech Biz and into CRO Sector
5/25/2011
-
Vyteris, Inc. Closes Merger with MediSync BioServices
4/18/2011
-
Gene E. Burleson, Healthcare Industry Executive and Director of Several NYSE-Listed Companies, Joins Vyteris, Inc. Board of Directors
12/16/2010
-
Vyteris, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11/10/2010
-
Vyteris, Inc. Receives $489,000 Grant Under the U.S. Qualifying Therapeutic Discovery Project Program
11/9/2010
-
Vyteris, Inc. Announces Definitive Agreement to Merge With Medisyn Technologies, Inc.
9/13/2010
-
Vyteris, Inc. to Present at Vyteris, Inc. Annual Global Investment Conference
9/7/2010
-
Vyteris, Inc. and Georgia Tech Enter Into Exclusive Agreement for Transdermal Drug Delivery Technologies
8/24/2010
-
Vyteris, Inc. Announces Positive Results From Phase II Clinical Trial of Transdermal Patch for Female Infertility
8/10/2010
-
Vyteris, Inc. Close to Signing $20 Million Deal for Product to Treat Female Infertility
8/6/2010
-
Vyteris, Inc. Expands Scientific Advisory Board With Four New Appointments
7/13/2010
-
Vyteris, Inc. to Present at OneMedForum New York 2010
6/25/2010
-
Vyteris, Inc. Appoints Joel Kanter to the Board of Directors
3/23/2010
-
Vyteris, Inc. Appoints Dr. Eugene A. Bauer as Chairman of the Board
2/17/2010
-
Vyteris, Inc. Announces Private Placement of $1.06 Million of Senior Subordinated Convertible Notes
2/8/2010
-
Vyteris, Inc. Announces Restructuring of Its Balance Sheet Through a $2.3 Million Non-Dilutive Capital Raise and Conversion of Approximately $20 Million of Debt and Preferred Shares Into Common Stock
12/29/2009
-
Vyteris, Inc. and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
4/14/2009
-
Vyteris, Inc. and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
4/14/2009
-
Vyteris, Inc. Announces Agreement for Additional Funding
3/25/2009
-
Vyteris, Inc. Initiates Phase II Clinical Trial of Infertility Treatment Using Smart Patch Technology
3/10/2009